AstraZeneca reported Q4 2025 sales of $15.50B, up 4% YoY. Adjusted EPS was $2.12. Cancer business accounted for 45% of sales. AstraZeneca Plc (NASDAQ:AZN) on Tuesday reported fourth-quarter 2025 sales...
Alphabet’s aggressive investment in AI is already translating into tangible business momentum. Alphabet (GOOGL) recently posted robust fourth-quarter and full-year results, with its annual reven...
International Business Machines has outperformed the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects. Founded in 1911, Armonk, New York-based Intern...
HAIN reported a 7% decline in net sales for Q2, with a net loss of $116 million. Divestiture of snack business aims to improve margins, Organic sales declined 7%, driven by a 9-point decrease in volum...
Shares in Stellantis (STLA) plunged 23.69% on Friday after the French-Italian-American automaker announced a business reset, moving to further s… Shares in Stellantis (STLA) plunged 23.69% on Fr...
Johnson & Johnson (JNJ) has a diversified business model that makes it resilient through economic cycles. JNJ is trading at new all-time highs. The stock maintains a 100% “Buy” technical opinion ...
Stellantis stock tanked after warning of a full-year net loss and announcing a business reset, including 22 billion euros in charges. Stellantis N.V. (NYSE:STLA) stock tanked Friday after the automake...
Amazon shares plunged after hours despite beating fourth-quarter revenue estimates as investors fixated on the company’s planned $200 billion AI spending push, even as Jim Cramer and analysts ar...
Amazon shares plunged after hours despite beating fourth-quarter revenue estimates as investors fixated on the company’s planned $200 billion AI spending push, even as Jim Cramer and analysts ar...
Microchip Technology edged above estimates for its fiscal Q3 and guided higher than views for fiscal Q4. But Microchip stock fell. Information in Investor’s Business Daily is for informational and edu...
